Ana L. Rodrigues
Florianopolis, SC 88040900, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Vitamin D in major depressive disorder: Current evidence, possible molecular mechanisms, and future prospects.
Journal: The Journal of steroid biochemistry and molecular biology
Published: December 12, 2025
Non-aversive handling in laboratory animals and its effects on depressive-like and anxiety-related behaviors: A scoping review.
Journal: Physiology & behavior
Published: December 29, 2024
Neuroplasticity-related effects of vitamin D relevant to its neuroprotective effects: A narrative review.
Journal: Pharmacology, biochemistry, and behavior
Published: September 09, 2024
Neuroinflammation in Alzheimer's disease: potential beneficial effects of vitamin D.
Journal: Metabolic brain disease
Published: October 30, 2022
NMDA receptor-mediated modulation on glutamine synthetase and glial glutamate transporter GLT-1 is involved in the antidepressant-like and neuroprotective effects of guanosine.
Journal: Chemico-biological interactions
Published: August 21, 2022
The antidepressant-like effect of guanosine involves the modulation of adenosine A1 and A2A receptors.
Journal: Purinergic signalling
Published: July 31, 2022
Guanosine as a promising target for fast-acting antidepressant responses.
Journal: Pharmacology, biochemistry, and behavior
Published: April 13, 2022
SARS-CoV-2 consequences for mental health: Neuroinflammatory pathways linking COVID-19 to anxiety and depression.
Journal: World journal of psychiatry
Published: January 20, 2022
Involvement of serotonergic neurotransmission in the antidepressant-like effect elicited by cholecalciferol in the chronic unpredictable stress model in mice.
Journal: Metabolic brain disease
Published: December 21, 2021
Prophylactic efficacy of ketamine, but not the low-trapping NMDA receptor antagonist AZD6765, against stress-induced maladaptive behavior and 4E-BP1-related synaptic protein synthesis impairment.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 04, 2021
The resilient phenotype elicited by ketamine against inflammatory stressors-induced depressive-like behavior is associated with NLRP3-driven signaling pathway.
Journal: Journal of psychiatric research
Published: July 26, 2021
Last Updated: 09/26/2026